At-home ketamine safety checklist: what is available at home

What is actually available at home?

Option	At home?	What it means	Main caution
Compounded oral/sublingual ketamine	Sometimes	Telehealth or hybrid prescription of compounded lozenges, troches, or rapid-dissolve tablets.	Not FDA-approved for psychiatric disorders; no onsite monitoring during acute effects.
Spravato (esketamine)	No	FDA-approved nasal spray for treatment-resistant depression and certain acute suicidal ideation indications.	Must be administered in a certified healthcare setting under REMS with at least two hours of monitoring.
Remote integration therapy	Yes	Preparation or post-session therapy by video with a licensed clinician or trained integration provider.	Useful support, but it is not legal remote dosing for Schedule I psychedelics.
Psilocybin, MDMA, LSD, ayahuasca, ibogaine, 5-MeO-DMT	No legal take-home treatment	These remain Schedule I federally in the US, except specific religious/state-regulated contexts that are not take-home medical treatment.	At-home sourcing or self-administration creates legal and safety risk.

Do not start with at-home dosing if any of these apply

Current crisis or unstable self-harm risk. At-home treatment is not a substitute for emergency or urgent psychiatric care.
Active psychosis, mania, or bipolar I instability. Ketamine can worsen psychiatric symptoms in vulnerable patients.
Uncontrolled hypertension, major cardiac disease, or recent cardiovascular event. Ketamine can raise blood pressure and heart rate.
Substance-use disorder or ketamine misuse risk. Ketamine has abuse and diversion risk; large take-home quantities are a red flag.
Pregnancy, seizure instability, or complex medical status. These need clinician review before any dosing model.
No sober support person or no safe setting. Dissociation, sedation, panic, or impaired coordination can happen during the session.
No follow-up plan. If the program cannot tell you who checks on you after dosing, pause.

Questions for an at-home ketamine program

Is the evaluation live video, phone-only, or just a form?
Who prescribes, and are they licensed in my state?
How do you check blood pressure and cardiac risk?
Do you require a sober support person during dosing?
How many doses ship at once, and how are refills controlled?
What symptoms mean I should stop and seek urgent care?
Do you coordinate with my psychiatrist or therapist?

Home setup before a dose

No driving, childcare, cooking, or machinery for the session window.
Use a calm room with a place to lie down and a clear path to the bathroom.
Have a sober support person reachable or present, based on the clinician's instructions.
Keep emergency contacts, medication list, allergies, and clinic phone number visible.
Store medication securely away from children, guests, and anyone else in the home.
Do not increase dose or frequency outside the prescribing plan.

Red flags

No clinician evaluation before shipment.
No blood-pressure or medical-history review.
Claims that compounded ketamine is FDA-approved for depression.
Unlimited refills or dose escalation without reassessment.
No plan for panic, vomiting, respiratory symptoms, or severe dissociation.
Marketing that frames ketamine as a guaranteed cure.

When in-clinic care is a better fit

You need insurance coverage, especially for Spravato.
You have blood-pressure, cardiac, or medication complexity.
You are worried about misuse or taking more than prescribed.
You live alone and cannot arrange support.
You want the most monitored version of ketamine care.

Official sources to know

FDA compounded ketamine warning

FDA warns that compounded ketamine products, including oral forms, are not FDA-approved for psychiatric disorders and that at-home use lacks onsite monitoring.

Read FDA warning (opens in new tab)

DEA telemedicine flexibilities

DEA and HHS extended controlled-substance telemedicine flexibilities through December 31, 2026, subject to DEA guidance, federal rules, and state law.

Read DEA update (opens in new tab)

Spravato REMS

Spravato is restricted to certified healthcare settings, with direct observation and at least two hours of monitoring. It is not take-home medication.

Visit Spravato REMS (opens in new tab)

Crisis support

If you are seeking at-home treatment because symptoms feel urgent or unsafe, use crisis support before provider shopping.

Crisis resources

Frequently asked

What psychedelic-adjacent treatment is actually available at home?

In the United States, the main legal at-home option is compounded oral or sublingual ketamine prescribed by a licensed clinician, usually through telehealth, where allowed by federal and state law. Remote integration therapy can also happen at home, but it is not dosing. Spravato, psilocybin, MDMA, LSD, ayahuasca, ibogaine, and 5-MeO-DMT are not legal take-home treatment options.

Can Spravato be taken at home?

No. Spravato is available only through the Spravato REMS and must be administered under direct observation in a certified healthcare setting with monitoring for at least two hours. It must never be dispensed directly to a patient for home use.

Is at-home compounded ketamine FDA-approved for depression?

No. FDA-approved ketamine is an injectable anesthetic, and Spravato is FDA-approved esketamine for certain depression indications under REMS. Compounded oral, sublingual, or nasal ketamine products are not FDA-approved for psychiatric disorders, and FDA has warned about risks when they are used at home without onsite monitoring.

Who should not start with at-home ketamine?

At-home ketamine is a poor starting point for anyone in suicidal crisis, anyone with active psychosis or mania, uncontrolled blood pressure or major cardiac risk, pregnancy, significant substance-use risk, no sober support person, no safe setting, or no reliable follow-up with a clinician.

Last reviewed: 2026-04-24. Tell us what's changed — corrections@mindmedicinelaw.com.